Pacira BioSciences, Inc.

PCRXNASDAQHealthcare● Active

$22.86

+$0.11(+0.48%)

Market Cap$899198100

P/E Ratio—

52W High$27.64

52W Low$18.8

Avg Volume611K

Open$22.70

Beta0.29

Net Income Financials Revenue

Pacira BioSciences, Inc. (PCRX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PCRX · net income · updated Jun 8, 2026

Core profitability metrics

PCRX · net income · margin · TTM · CAGR

Net income was $7.0M for FY2025 (fiscal year ending 2025-12-31), up 107.1% year-over-year. Net profit margin was 1.0%. Based on available data, Pacira BioSciences, Inc. has been profitable since at least 2015.

FY2025 Net Income$7.0M▲ +107.1% YoY

Trailing 12M (TTM)$5.1Mtrailing 4 quarters sum

Net Profit Margin1.0%$7.0M ÷ $726.4M

YoY Change+107.1%—

5-Year CAGR-45.4%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2015

▸ FMP /income-statement · Annual · PCRX net income history · PCRX profit margin

Annual net income data

PCRX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$7.0M▲ +107.1%1.0%$726.4M

FY2024Loss−$99.6M▼ 337.3%-14.2%$701.0M

FY2023$42.0M▲ +163.7%6.2%$675.0M

FY2022$15.9M▼ 62.1%2.4%$666.8M

FY2021$42.0M▼ 71.2%7.8%$541.5M

Net income vs peers (Healthcare)

PCRX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Pacira BioSciences, Inc.YOU

PCRX

$7.0M+107.1%1.0%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Pacira BioSciences, Inc. (PCRX) reported net income of $7.0M for FY2025 (fiscal year ending 2025-12-31), up 107.1% year-over-year. The net profit margin was 1.0% — meaning the company kept $0.01 of every dollar of revenue as profit.

Based on available data, Pacira BioSciences, Inc. has been profitable since at least 2015. Net income reached a peak of $145.5M in FY2020. Data available for 15 fiscal years.

Pacira BioSciences, Inc.'s net profit margin was 1.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Pacira BioSciences, Inc. net worth" — the company's market capitalization is a separate figure from PCRX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

PCRX net income · 5 questions

Pacira BioSciences, Inc. is profitable. The company reported net income of $7.0M for FY2025, a net profit margin of 1.0%. Net income was up 107.1% year-over-year. Based on available data, Pacira BioSciences, Inc. has been profitable since at least 2015.

is PCRX profitabledoes PCRX make a profitPCRX profitabilityPCRX profitable company

▸ Source: FMP /income-statement · GAAP · Pacira BioSciences, Inc. · Pacira BioSciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026